Strong cytotoxic T lymphocyte responses to a macrophage inflammatory protein 1α-expressing tumor: Linkage between inflammation and specific immunity

Cancer Research

Volumn 59, Issue 21, 1999, Pages 5549-5553

  Maric, Maja ^c   Liu, Yang ^a,b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; IMMUNE RESPONSE; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR RESISTANCE;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; DRUG SCREENING ASSAYS, ANTITUMOR; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; PLASMACYTOMA; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0033230494     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Janeway, C. A., Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today, 13: 11-16, 1992.
2. Janeway, C. A., Jr., and Bottomly, K. Signals and signs for lymphocyte responses. Cell, 76: 275-285, 1994.
3. Liu, Y., and Janeway, C. A., Jr. Microbial induction of co-stimulatory activity for CD4 T-cell growth. Int. Immunol., 3: 323-332, 1991.
4. Matzinger, P. Immunology. Memories are made of this? Nature (Lond.), 369: 605-606, 1994.
5. Nathan C. F., Hill, V. M., and Terry W. D. Isolation of a subpopulation of adherent peritoneal cells with anti-tumour activity. Nature (Lond.), 260: 146-148, 1976.
6. Nathan, C. F., Brukner, L. H., Silverstein, S. C., and Cohn, Z. A. Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide. J. Exp. Med., 149: 1056-1068, 1979.
7. Kiessling, R., Klein, E., Pross, H., and Wigzell, H. "Natural killer" cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur. J. Immunol., 5: 117-121, 1975.
8. Stuehr, D. J., and Nathan, C. F. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med., 169: 1543-1555, 1989.
9. Sherry, B., and Cerami, A. Small cytokine superfamily. Curr. Opin. Immunol., 3: 56-60, 1991.
10. Tanaka, Y., Adams, D., Hubscher, S., Hirano, H., Siebenlist, U., and Shaw, S. T cell adhesion induced by proteoglycan-immobilized cytokine-1β. Nature (Lond.), 361: 79-82, 1993.
11. + T cells in response to MIP1α and MIP1β. Science (Washington DC), 260: 355-358, 1993.
12. Schall, T. J., Bacon, K., Camp, R. D. R., Kaspari, J. W., and Goeddel, D. V. Human macrophage inflammatory protein a (MIP1α) and MIP1β chemokines attracts distinct populations of lymphocytes. J. Exp. Med., 177: 1821-1826, 1993.
13. Cook, D. N., Beck, M. A., Coffman, T. M., Kirby, S. L., Sheridan, J., Pragnell, I. B., and Smithies, O. Requirement of MIP1α for an inflammatory response to viral infection. Science (Washington DC), 269: 1583-1585, 1995.
14. Marie, M., Chen, L., Sherry, B., and Liu, Y. A mechanism for selective recruitment of CD8 T cells into a B7-1-transfected plasmacytoma: role of macrophage inflammatory protein 1α. J. Immunol., 159: 360-368, 1997.
15. Ramarathinam, L., Castle, M., Wu, Y., and Liu, Y. T cell costimulation by B7/BBI induces CD8 T cell-dependent tumor rejection: an important role of B7/BBI in the induction, recruitment, and effector function of antitumor T cells. J. Exp. Med., 179: 1205-1214, 1994.
16. Dumont, F. J., Habbrtsett, R. C., Coker, L. C., Nichols, E. A., and Treffinger, E. A. High level expression of the plasma cell antigen PC.1 on the T cell subset expanding in MRL/MpJ-lpr/lpr mice: detection with a xenogeneic monoclonal antibody and allo antisera. Cell. Immunol., 96: 327-338, 1985.
17. Wu, Y., Guo, Y., and Liu, Y. A major co-stimulatory molecule, CTLA4 ligand A, is distinct from B7. J. Exp. Med., 178: 1789-1793, 1993.
18. Razi-Wolf, Z., Freeman, G. J., Galvin, F., Benacerraf, B., Nadle, L., and Reiser, H. Expression and function of the murine B7-antigen, the major costimulatory molecule expressed by peritoneal exudate cells. Proc. Natl. Acad. Sci. USA, 89: 4210-4215, 1992.
19. Hathcock, K. S., Laszlo, G., Dickler, H. B., Bradshaw, J., Linsley, P. S., and Hodes, R. J. Identification of an alternative CTLA4 ligand co-stimulatory for T cell activation. Science (Washington DC), 262: 905-907, 1993.
20. Austyn, J. M., and Gordon, S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol., 11: 805-815, 1981.
21. Metlay, J. P., Witmer-Pack, M. D., Agger, R., Crowley, M. T., Lawless, D. S., and Steinman, R. M. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J. Exp. Med., 171: 1753-1763, 1990.
22. Coffman, R. L., and Weissman, I. L. B220: a B cell-specific member of the T200 glycoprotein family. Nature (Lond.), 289: 681-683, 1981.
23. Lethe, B., Van der Eynde, B., Van Pel, A., Corradin, G., and Boon, T. Mouse tumor rejection antigen P815A and P815B: two epitopes carried by a single peptide. Eur. J. Immunol., 22: 2283-2288, 1992.
24. Ramarathinam, R., Sarma, S., Marie, M., Zhao, M., Yang, G., Chen, L., and Liu, Y. Multiple lineages of tumors express a common tumor antigen. P1A, but they are not cross-protected. J. Immunol., 155: 5323-5329, 1995.
25. Maric, M., Zheng, P., Sarma, S., Guo, Y., and Liu, Y. Maturation of cytotoxic T lymphocytes against a B7-transfecled nonmetastatic tumor: a critical role for costimulation by B7 on both tumor and host Antigen-presenting cells. Cancer Res., 58: 3376-3384, 1998.
26. Green, E. A., Eynon, E. E., and Flavell, R. A. Local expression of TNFα in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity, 9: 733-743, 1998.
27. Kundig, T. M., Bachmann, M. F., DiPaolo, C., Simard, J. L. J., Battegay, M., Lother, H., Gessner, A., Kuhlcke, K., Ohashi, P. S., Hengartner, H., and Zinkemagel, R. M. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science (Washington DC), 268: 1343-1346, 1995.
28. Banchereau, J., and Steinman, R. M. Dendritic cells and the control of immunity. Nature (Lond.), 392: 245-248, 1998.
29. Huang, A. Y., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., and Levitsky, H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science (Washington DC), 264: 961-963, 1994.
30. Cella, M., Engering, A., Pinet, V., Pieters, J., and Lanzavecchia, A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature (Lond.), 388: 782-784, 1997.
31. Da Fano, C. Zellulare analyse der geschwuistmmunitåtsreaktionen. Z. Immunitaetsforch., 5: 1-75, 1910.
32. Richardson, W. W. Medullary carcinoma of the breast. A distinctive tumor type with a relatively good prognosis following radical mastectomy. Br. J. Cancer, 10: 415-423, 1956.
33. Chen, L. P., Ashe, S., Brady, W. A., Hellstrom, I., Hellstrom, K. E., Ledbetter, J. A., McGowan, P., and Linsley, P. S. Costimulation of anti-tumor immunity by the B7 counter receptor for the T lymphocyte molecules CD28 and CTLA4. Cell, 71: 1093-1202, 1992.
34. + T cells by B7-transfected melanoma cells. Science (Washington DC), 259: 368-370, 1993.
35. Baskar, S., Ostrand-Rosenberg, S., Nabavi, N., and Glimcher, L. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated MHC class II molecules. Proc. Natl. Acad. Sci. USA, 90: 7015-7019, 1993.
36. Sarma, S., Guo, Y., Guilloux, Y., Lee, C., Bai, X-F., and Liu, Y. Cytotoxic T lymphocytes to an unmutated tumor antigen P1A: normal development but restrained effector function. J. Exp. Med., 189: 811-820, 1999.
37. Wu, T. C., Huang, A. Y., Jaffee, E. M., Levitsky, H. I., and Pardoll, D. M. A reassessment of the role of B7-1 expression in tumor rejection. J. Exp. Med., 182: 1415-1421, 1995.
38. Chong, H., Hutchinson, G., Hart, I. R., and Vile, R. G. Expression of B7 co-stimulatory molecules by B16 melanoma results in a natural killer cell-dependent local anti-tumour response, but induces T- cell-dependent systemic immunity only against B7-expressing tumours. Br. J. Cancer, 78: 1043-1050, 1998.
39. Zheng, P., Sarma, S., Guo, Y., and Liu, Y. Two mechanisms for tumor evasion of host immunity: lessons from recurrent tumors. Cancer Res., 59: 3461-3467, 1999.